Q4 FY2025 Earnings
Financial report interval: 2024.12.31 - 2025.03.31
Overview: Portage Biotech(PRTG) the EBIT is -1.48 M (+54.6%);the EPS is -1.44 (+93.94%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.00B54.60%
----
----
EPS
-1.439493.94%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf